BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mak LY, To WP, Wong DKH, Fung J, Liu F, Seto WK, Lai CL, Yuen MF. Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients. World J Gastroenterol 2019; 25(11): 1398-1408 [PMID: 30918432 DOI: 10.3748/wjg.v25.i11.1398]
URL: https://www.wjgnet.com/1007-9327/full/v25/i11/1398.htm
Number Citing Articles
1
Kantoku Nagakawa, Masaaki Hidaka, Takanobu Hara, Hajime Matsushima, Hajime Imamura, Takayuki Tanaka, Tomohiko Adachi, Akihiko Soyama, Kengo Kanetaka, Susumu Eguchi, Jincheng Wang. Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosisPLOS ONE 2023; 18(11): e0293593 doi: 10.1371/journal.pone.0293593
2
Lung-Yi Mak. Disease modifiers and novel markers in hepatitis B virus-related hepatocellular carcinomaJournal of Liver Cancer 2024; 24(2): 145 doi: 10.17998/jlc.2024.08.03
3
Tai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, Tung-Hung Su, Chia-Chi Wang, Chun-Jen Liu, Hung-Chih Yang, Wan-Ting Yang, Chia-Hsin Lin, Ming-Lung Yu, Hsueh-Chou Lai, Yasuhito Tanaka, Mindie H. Nguyen, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyLiver Cancer 2020; 9(2): 207 doi: 10.1159/000504650
4
Lung-Yi Mak, Danny Ka-Ho Wong, Ka-Shing Cheung, Rex Wan-Hin Hui, Fen Liu, James Fung, Wai-Kay Seto, Man-Fung Yuen. Role of Serum M2BPGi Levels in Predicting Persistence of Advanced Fibrosis in Chronic Hepatitis B Virus InfectionDigestive Diseases and Sciences 2022; 67(11): 5127 doi: 10.1007/s10620-022-07429-4
5
Chih-Lin Lin, Jia-Horng Kao. Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infectionClinical and Molecular Hepatology 2023; 29(3): 605 doi: 10.3350/cmh.2022.0342
6
Ian Baudi, Takako Inoue, Yasuhito Tanaka. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGiInternational Journal of Molecular Sciences 2020; 21(3): 949 doi: 10.3390/ijms21030949
7
Shu Feng, Zhonghao Wang, Yanhua Zhao, Chuanmin Tao. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67471-y
8
Takako Inoue, Yasuhito Tanaka. Novel biomarkers for the management of chronic hepatitis BClinical and Molecular Hepatology 2020; 26(3): 261 doi: 10.3350/cmh.2020.0032
9
Takako Inoue, Yasuhito Tanaka. Comprehensive Guide to Hepatitis Advances2023; : 31 doi: 10.1016/B978-0-323-98368-6.00009-4
10
Nicky Somers, Emma Butaye, Lorenz Grossar, Nele Pauwels, Anja Geerts, Sarah Raevens, Sander Lefere, Lindsey Devisscher, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst. Glycomics as prognostic biomarkers of hepatocellular carcinoma: A systematic reviewOncology Letters 2024; 29(1) doi: 10.3892/ol.2024.14769
11
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker DevelopmentJournal of Clinical Medicine 2021; 10(5): 977 doi: 10.3390/jcm10050977
12
Amr Shaaban Hanafy, Khalid Ali Muftah Abdelaziz, Fedaa Nabil Mohammad, Amr Samir Ibrahim. Mac-2 binding protein glycosylation isomer as a potential biomarker of hepatocellular carcinoma in HCV-cured patientsEgyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00389-6
13
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An UpdateViruses 2021; 13(7): 1333 doi: 10.3390/v13071333